Celanese (CE) director converts 1,808 phantom stock units into common shares

Rhea-AI Filing Summary

Celanese Corporation director Kathryn Hill reported a routine equity compensation transaction. On January 1, 2026, she converted 1,808.351 shares of phantom stock into 1,808.351 shares of Celanese common stock at a price of $0 per share under the company’s 2008 Deferred Compensation Plan.

After this conversion, she directly held 16,808.48 shares of common stock and 1,140.519 phantom stock units. Each phantom stock unit represents the right to receive one share of common stock, payable in shares as provided by the deferred compensation plan.

Insider Trade Summary

1,808.351 shares exercised/converted

Mixed 2 txns

Insider Hill Kathryn

Role Director

Type	Security	Shares	Price	Value
Conversion	Phantom Stock	1,808.351	$0.00	--
Conversion	Common Stock	1,808.351	$0.00	--

Holdings After Transaction: Phantom Stock — 1,140.519 shares (Direct); Common Stock — 16,808.48 shares (Direct)

Footnotes (1)

1. Each share of phantom stock represents the right to receive one share of Common Stock. The reported phantom stock represents compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hill Kathryn

(Last) (First) (Middle)

C/O CELANESE CORPORATION

222 W. LAS COLINAS BLVD., SUITE 900N

(Street)

IRVING TX 75039

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Celanese Corp [ CE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/01/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/01/2026		C		1,808.351	A	$0	16,808.48	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Phantom Stock	(1)	01/01/2026		C			1,808.351	(2)	(2)	Common Stock	1,808.351	$0	1,140.519	D

Explanation of Responses:

1. Each share of phantom stock represents the right to receive one share of Common Stock.

2. The reported phantom stock represents compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan.

Remarks:

	/s/ Christine Dryden, Attorney-in-Fact for Kathryn Hill	01/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Celanese (CE) director Kathryn Hill report?

Celanese director Kathryn Hill reported converting 1,808.351 phantom stock units into 1,808.351 shares of common stock at $0 per share. This was a routine compensation-related transaction under the company’s 2008 Deferred Compensation Plan, not an open-market purchase or sale.

How many Celanese (CE) common shares does Kathryn Hill hold after this Form 4?

Following the reported transaction, Kathryn Hill directly holds 16,808.48 shares of Celanese common stock. This reflects the addition of 1,808.351 shares received from converting phantom stock under the company’s deferred compensation plan on January 1, 2026.

What is phantom stock in the context of Celanese (CE) compensation?

At Celanese, each phantom stock unit represents the right to receive one share of common stock. These units are granted as deferred compensation and become payable in actual shares of common stock under the terms of the company’s 2008 Deferred Compensation Plan.

How many phantom stock units does Kathryn Hill still hold in Celanese (CE)?

After converting some phantom stock, Kathryn Hill holds 1,140.519 phantom stock units. Each unit corresponds to one future share of Celanese common stock, deliverable according to the company’s 2008 Deferred Compensation Plan provisions.

Was there any cash involved in Kathryn Hill’s Celanese (CE) Form 4 transaction?

No cash changed hands in this transaction. The Form 4 shows a conversion of 1,808.351 phantom stock units into the same number of Celanese common shares at a reported price of $0 per share as part of deferred compensation.

Is Kathryn Hill’s Celanese (CE) Form 4 transaction an open-market trade?

The transaction is not an open-market trade. It is coded as a conversion (Code C), reflecting the settlement of deferred phantom stock into Celanese common shares under the 2008 Deferred Compensation Plan rather than a market buy or sell.